unknown
Stage
About
Adirna Therapeutics develops RNA-based precision medicines by targeting non-coding regions of the genome using AI-driven target discovery and therapeutic development platforms.
Explore Adirna Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.